Eva Hoster

21PUBLICATIONS

113CO-AUTHORS

Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|Jul 07, 2026

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

|Nov 03, 2025

Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial.

Mouhamad Khouja, Elisa Genuardi, Simone Ferrero

|Apr 24, 2025

Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.

Clémentine Sarkozy, Loïc Chartier, Vincent Ribrag

|Feb 24, 2025

Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.

Ricarda Knabe, Philippe Muller, Christoph Schliemann

|Feb 21, 2025

BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma.

Katja Gutmair, Diego Villa, Nicholas Cunningham

|Oct 23, 2024

Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL Network.

Linmiao Jiang, Martin Dreyling, Olivier Hermine

Pageof 4

Frequent Collaborators

Linmiao Jiang

Wolfram Klapper

Christiane Pott

Martin Dreyling

Gilles Salles

David W Scott

Catherine Thieblemont

3 joint publications

Johanna C Kluin-Nelemans

3 joint publications

Marion Subklewe

3 joint publications

Veit L Bücklein

Frequent Collaborators

Linmiao Jiang

Wolfram Klapper

Christiane Pott

Martin Dreyling